Back to search

Article

Pyridoxine supplementation confers protection against <i> SGPL1 <sup>R222Q</sup> </i> variant sphingosine phosphate lyase insufficiency syndrome

2026-05-14

Abstract excerpt

Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) is a rare condition causing nephrotic syndrome, neuropathy, and other manifestations. SPLIS is caused by mutations in SGPL1 , which encodes sphingosine-1-phosphate lyase (SPL), a pyridoxal 5’-phosphate (PLP)-dependent enzyme needed to degrade the bioactive sphingolipid sphingosine-1-phosphate (S1P). Supplementation with the PLP precursor pyridoxine bene...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
83f25830-640e-5bbc-9759-1183bd8e4fcb
DOI
10.64898/2026.05.11.724358
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pyridoxine supplementation confers protection against <i> SGPL1 <sup>R222Q</sup> </i> variant sphingosine phosphate lyase insufficiency syndromeDOI 10.64898/2026.05.11.724358
Select a neighboring publication to make it the new centre.